Trademark Overview
On Monday, June 8, 2026, a trademark application was filed for PRECISIONUTR with the United States Patent and Trademark Office. The USPTO has given the PRECISIONUTR trademark a serial number of 99871734. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 8, 2026. This trademark is owned by Novo Vessel Inc.. The PRECISIONUTR trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical and biotechnology research, development, and consulting services in the field of gene therapy and mRNA technology; laboratory research services in the field of gene therapy and mRNA technology; Contract Research Organization (CRO) services in the field of biotechnology, namely, gene therapy and mRNA technology; platform-as-a-service (PaaS) services featuring artificial intelligence for engineering and optimization of mRNA regulatory elements to enhance expression, translation efficiency, tissue specificity, and therapeutic performance; providing online non-downloadable computer software platforms for analyzing, sequencing, and identifying mRNA-based therapeutics
laboratory apparatus and instruments for use in biology research and discovery in the field of gene therapy and mRNA technology; scientific apparatus and instruments for the analysis and sequencing of mRNA sequences for research and laboratory use; laboratory apparatus and instruments for identifying mRNA-based therapeutics; recorded computer software for controlling laboratory instruments and analyzing and sequencing mRNA sequences
pharmaceutical and biological preparations for medical use in the field of gene therapy and mRNA technology; mRNA therapeutics for promoting blood vessel formation; gene therapy preparations for promoting blood vessel formation